PH25286A - Sustained release drug preparation - Google Patents

Sustained release drug preparation

Info

Publication number
PH25286A
PH25286A PH8735554A PH35554A PH25286A PH 25286 A PH25286 A PH 25286A PH 8735554 A PH8735554 A PH 8735554A PH 35554 A PH35554 A PH 35554A PH 25286 A PH25286 A PH 25286A
Authority
PH
Philippines
Prior art keywords
release drug
sustained release
drug preparation
sustained
drug
Prior art date
Application number
PH8735554A
Other languages
English (en)
Inventor
Hidenobu Andoh
Sumio Waranabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH25286A publication Critical patent/PH25286A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH8735554A 1986-07-18 1987-07-17 Sustained release drug preparation PH25286A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤

Publications (1)

Publication Number Publication Date
PH25286A true PH25286A (en) 1991-04-30

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
PH8735554A PH25286A (en) 1986-07-18 1987-07-17 Sustained release drug preparation

Country Status (13)

Country Link
US (1) US5030455A (da)
EP (1) EP0254978B1 (da)
JP (1) JPH0816066B2 (da)
KR (1) KR960004857B1 (da)
AT (1) ATE71291T1 (da)
CA (1) CA1309656C (da)
DE (1) DE3775850D1 (da)
DK (1) DK174931B1 (da)
ES (1) ES2040228T3 (da)
FI (1) FI96095C (da)
GR (1) GR3003536T3 (da)
NO (1) NO179163C (da)
PH (1) PH25286A (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
DK1473031T3 (da) * 1993-12-13 2008-10-20 Avanir Pharmaceuticals Sucroseester - C20 til C28 alkoholformuleringer
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
EP0873127B1 (en) * 1995-09-25 2006-11-15 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE69730218D1 (de) * 1996-04-11 2004-09-16 Univ British Columbia Fusogene liposomen
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법
MXPA04003807A (es) * 2001-11-30 2004-07-30 Pfizer Prod Inc Formulaciones farmaceuticas de 5, 7, 14-trianzatetraciclo [10.3.1.02, 11, 04, 9]-hexadeca -2 (11), 3, 5, 7, 9-pentaeno.
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
CN103249510B (zh) * 2010-12-08 2016-05-18 会田工程技术有限公司 高强度烧结成形体的制造方法及其制造装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
EP0176772B1 (de) * 1984-08-30 1989-03-29 RODISMA Pharmazeutische Produkte GmbH Verfahren zur Retardierung von Vitamin C und E

Also Published As

Publication number Publication date
ATE71291T1 (de) 1992-01-15
ES2040228T3 (es) 1993-10-16
KR880001301A (ko) 1988-04-22
CA1309656C (en) 1992-11-03
DK174931B1 (da) 2004-03-01
FI873106A (fi) 1988-01-19
JPS6327439A (ja) 1988-02-05
NO872991D0 (no) 1987-07-17
DE3775850D1 (de) 1992-02-20
DK373187A (da) 1988-01-19
NO872991L (no) 1988-01-19
EP0254978B1 (en) 1992-01-08
FI96095B (fi) 1996-01-31
JPH0816066B2 (ja) 1996-02-21
US5030455A (en) 1991-07-09
FI96095C (fi) 1996-05-10
KR960004857B1 (ko) 1996-04-16
EP0254978A1 (en) 1988-02-03
GR3003536T3 (da) 1993-03-16
DK373187D0 (da) 1987-07-17
NO179163C (no) 1996-08-21
FI873106A0 (fi) 1987-07-14
NO179163B (no) 1996-05-13

Similar Documents

Publication Publication Date Title
PH25286A (en) Sustained release drug preparation
GB8501015D0 (en) Drug
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
EP0295903A3 (en) Hair preparation
DE3778366D1 (de) Sich automatisch zerstoerende einweg-injektionsspritze.
DE69025920D1 (de) Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten
DE3787377D1 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
BG49827A3 (en) Method for preparing a clean byologic active recombinative human colonium stimulating factor
ES2065906T3 (es) Produccion de proteinas en formas activas.
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
ATE84213T1 (de) Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
IT8722264A0 (it) Procedimento per la preparazione di compresse solubili e/o divisibili e compresse cosi' ottenute.
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
EP0250115A3 (en) 2,5-pyrrolidine dione derivatives obtained from bacteriae, and their use as bactericides
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
IT1216894B (it) Composizione farmaceutica eprocedimento per la sua preparazione.
ATE77820T1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
IT8820095A0 (it) Uso della vitamina b2 (riboflavina 0 5 fosfato della riboflavina)nnella cura della parodontosi degli anziani.